Page 11 - Pascal Touchon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascal touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascal Touchon Today - Breaking & Trending Today

Insider Selling: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) CEO Sells $23,723.06 in Stock

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) CEO Pascal Touchon sold 14,291 shares of the stock in a transaction on Tuesday, June 27th. The shares were sold at an average price of $1.66, for a total value of $23,723.06. Following the completion of the transaction, the chief executive officer now directly owns 706,671 shares in […] ....

United States , Pascal Touchon , Zurcher Kantonalbank Zurich Cantonalbank , American Century Companies Inc , Lazard Asset Management , Tower Research Capital , Atara Biotherapeutics Inc , Atara Biotherapeutics Company Profile , Free Report , Research Capital , Kantonalbank Zurich Cantonalbank , Asset Management , Sigma Investments , American Century Companies ,

Brokerages Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Target Price at $19.38

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) has received a consensus recommendation of “Hold” from the seven research firms that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. […] ....

Hong Kong , United States , Pascal Touchon , Envestnet Asset Management Inc , Atara Biotherapeutics Inc , Hong Kong Ltd , Tower Research Capital , Lazard Asset Management , Atara Biotherapeutics Company Profile , Securities Exchange Commission , Free Report , Marketbeat Ratings , Exchange Commission , Kong Ltd , Research Capital , Sigma Investments , Asset Management , Envestnet Asset Management ,

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) CEO Pascal Touchon Sells 14,291 Shares

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) CEO Pascal Touchon sold 14,291 shares of Atara Biotherapeutics stock in a transaction that occurred on Tuesday, June 27th. The shares were sold at an average price of $1.66, for a total value of $23,723.06. Following the transaction, the chief executive officer now owns 706,671 shares of the […] ....

United States , Pascal Touchon , Metlife Investment Management , York Mellon Corp , Securities Exchange Commission , Dimensional Fund Advisors , Envestnet Asset Management Inc , Atara Biotherapeutics Inc , Alphacrest Capital Management , Free Report , Exchange Commission , Asset Management , New York Mellon Corp , Crest Capital Management , Life Investment Management , Fund Advisors ,

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives $19.38 Consensus PT from Brokerages

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and three have assigned a buy recommendation to the […] ....

United States , Pascal Touchon , Lazard Asset Management , Hennion Walsh Asset Management Inc , Atara Biotherapeutics Inc , Allspring Global Investments Holdings , Alpine Global Management , Free Report , Asset Management , Global Investments Holdings , Global Management , Walsh Asset Management ,

Atara Biotherapeutics' (ATRA) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) in a report published on Wednesday, The Fly reports. HC Wainwright currently has a $28.00 price target on the biotechnology company’s stock, up from their previous price target of $27.00. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 2023 […] ....

United Kingdom General , United Kingdom , Pascal Touchon , Atara Biotherapeutics Company Profile , Blackrock Inc , Wasatch Advisors Inc , Baupost Group , Atara Biotherapeutics Inc , Jpmorgan Chase Co , Securities Exchange Commission , Get Rating , Exchange Commission , Street Corp , Wasatch Advisors ,